SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹27 Cr | ₹24 Cr | ₹26 Cr | ₹10 Cr | ₹6.79 Cr |
What is the latest Total Current Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹27 Cr |
| Mar2025 | ₹24 Cr |
| Mar2024 | ₹26 Cr |
| Mar2020 | ₹10 Cr |
| Mar2019 | ₹6.79 Cr |
How is Total Current Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹27 Cr | 10.55 | |
| Mar2025 | ₹24 Cr | -6.65 | |
| Mar2024 | ₹26 Cr | 149.96 | |
| Mar2020 | ₹10 Cr | 52.89 | |
| Mar2019 | ₹6.79 Cr | - | |
Compare Total Current Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹854.5 Cr | -5.5% | 1.1% | 28.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.2% | -5.1% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.8% | -3.2% | 51.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.7% | -7.7% | 29.9% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0.6% | -3.8% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 2.9% | 4.6% | 0.4% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -5.5% |
1.1% |
28.8% |
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses